MTM1 and X-linked myotubular myopathy: As a primary goal of this study was to identify drugs suitable for translation to XLMTM patients, we next tested valproic acid (VPA) and trichostatin A (TSA) for efficacy in an orthogonal model, the well described Mtm1−/y knockout (KO) mouse[13].